(MENAFN- GlobeNewsWire - Nasdaq) BERKELEY HEIGHTS, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing ...
Presentation to feature complete safety and immunogenicity dataset from the Phase 1 clinical study of VBI-1501 Oral presentation at IDWeek 2018 on Saturday, October 6 th, 2018, at 11:10 AM PDT ...
Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — David J. Weber, MD, MPH, weighed in on findings from the Society of Healthcare Epidemiology of ...
MedImmune, the global biologics arm of AstraZeneca PLC, has approximately 3,500 employees worldwide and is headquartered in Gaithersburg, Maryland. For more information, visit MedImmune's website at ...
MORRISTOWN, N.J.--(BUSINESS WIRE)-- Durata Therapeutics (Nasdaq: DRTX) today announced that data from two clinical trials of its lead product candidate, dalbavancin, will be presented in two posters ...
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback